Latest News

MSNZ Submission on the Online Casino Gambling Bill

August 21, 2025 | Advocacy, News

MSNZ supports the Government’s intentions to use portions of the tax revenue from gambling to fund services to treat gambling harm. However, the proposed new Online Casino Gambling Bill puts the sustainability of many MS community services and organisations at […]


MSNZ Submission on the Healthy Futures (Pae Ora) Amendment Bill

August 21, 2025 | Advocacy, News

MSNZ supports the Government’s intentions to implement and mandate a long-term mental health and wellbeing strategy. People with MS have a significantly high incidence of mental health conditions, particularly depression and anxiety. Outcomes are greatly improved with routine access to […]


MS Diagnosis Surges 67% in NZ: Māori Disparities Highlight Urgent Need for Neurological Care Investment

June 17, 2025 | Advocacy, Media, News

Neil Woodhams, President of Multiple Sclerosis New Zealand, joined Dale Husband on Waatea News to discuss the recent study which showed a 67% surge of MS diagnoses in New Zealand since 2006 and the Māori disparities that highlight the urgent […]


1News Report – Medsafe Approves 10 Minute Ocrevus Injection

April 30, 2025 | Advocacy, Life with MS, Media, News, Treatments

Watch Graham Walker, person with MS, President of MS Taranaki and Co-Vice President of MSNZ discuss the life-changing news that Medsafe has approved the 10 minute Ocrevus injection, accompanied with comments from Amanda Rose, MSNZ National Manager on 1News, 29th […]


Ocrelizumab Subcut Receives Medsafe Registration as Pressure Mounts to Fund Wider Range of MS Treatment Options

April 24, 2025 | Advocacy, Life with MS, News, Treatments

Photo by Kristine Wook, Unsplash. Medsafe have approved the registration of Ocrevus ® Subcutaneous (SC) (ocrelizumab and hyaluronidase) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The announcement on […]